Paul B. Thames, M.D

Paul B. Thames, M.D

Dr. Paul Thames has been a practicing Ophthalmologist and Ophthalmic Surgeon in Texas for over twenty-five years. His areas of specialty include refractive, cataract and oculoplastic surgery. Respected by his patients and peers alike, Dr. Thames is a noted speaker in the ophthalmic community, and has contributed publications in ophthalmology and neurology. In addition to being an Ophthalmic Surgeon with the Abilene Eye Institute, Dr. Thames has been on staff at Abilene Regional Medical Center and Hendrick Medical Center in Abilene since 1983.

Dr. Thames received his undergraduate degree in Zoology at Texas Tech University before going on to earn his Medical Doctorate Degree at Texas Southwestern Medical School in Dallas. He remained in Dallas for his internship at Baylor University Medical Center, and then moved to Florida where he completed his residency at the University of Florida – College of Medicine, Shands Hospital and the VA Medical Center in Gainesville, and University Hospital in Jacksonville, Florida.

In the mid-1990s, Dr. Thames worked with other experts in his field to develop specialized instruments for insertion of intraocular lens implants. These surgical tools are currently used all over the world to assist in foldable lens implant procedures.

Certified by the American Board of Eye Surgery, Dr. Thames is also a Fellow of the American Board of Ophthalmology and the American College of Surgeons. He is a member of several professional societies including, Alpha Omega Alpha – Honor Medical Society, the American Academy of Ophthalmology, the American Society of Cataract & Refractive Surgery and the Texas Ophthalmology Association.

Dr. Thames is a proud Native Texan who has an affinity for Texas heritage and preservation. When he is not practicing Ophthalmology, he enjoys fly fishing, spending time with his wife, Gail, and visiting his farm in Buffalo Gap, Texas. Dr. Paul Thames proudly practiced at Abilene Eye Institute for over 30 years. He retired at the end of June of 2018.